Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of HPV Integration on the Prognosis of Women With Persistent HR-HPV Infection：a Multi-center Cohort Study in China

NCT05283239 is registered in ClinicalTrials.gov with Fujian Maternity and Child Health Hospital as lead sponsor.

NCT NCT05283239
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05283239 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of HPV Integration on the Prognosis of Women With Persistent HR-HPV Infection：a Multi-center Cohort Study in China
Lead sponsor
Fujian Maternity and Child Health Hospital
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2022
Completion date
December 31, 2024
Enrollment
1,000 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

hpv infection, hsil, high-grade squamous intraepithelial lesions, lsil, low-grade squamous intraepithelial lesions, virus integration